Skip to content

Evaluation of Quality of Sleep and Antioxidation power and immunity power with mattress of Four-layer special three-dimensional structure

Evaluation of Quality of Sleep and Antioxidation power and immunity power with mattress of Four-layer special three-dimensional structure - Evaluation of Quality of Sleep and Antioxidation power and immunity power with mattress of Four-layer special three-dimensional structure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000024644
Enrollment
12
Registered
2016-11-01
Start date
2016-10-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N/A (healthy adults or adults with sleep disorder)

Interventions

Using of mattress of Four-layer special three-dimensional structure

Sponsors

Anti-Aging Bank Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: [1]Japanese males and females aged 40-65 years [2]Individuals who are healthy and are not received treatment of disease [3]Individuals whose BMI is 18.5-25.0 [4]Individuals who are not satisfy quality of sleep [5]Individuals whose sleeping hours are over 4 hours from lights-out to rising and time of lights-out and rising is regular and bedtime is every 24th hours [6]Individuals who use a quilt [7]Individuals by whom going to bed by a single person is possible using in the test duration and a test mattress [8]Individuals whose written informed consent has been obtained [9]Individuals judged appropriate for the study by the principal

Exclusion criteria

Exclusion criteria: [1]Individuals using medical products [2]Individuals who are suspected, recived treatment of, or have a history of sleep apnea syndrome [3]Individuals who have or are suspected with the night urination, prostatomegaly, or overactive bladder [4]Individuals who have a history of serious hepatopathy, kidney damage, heart disease and hematological disease [5]Individuals with skin disease, such as atopic dermatitis [6]Individuals who have a history of hepatitis [7]Individuals with serious anemia [8]Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplyments in the past 3 month or will ingest those foods during the test period [9]Individuals who excessively take alcohol (expressed in an amount of alcohol: over 60mg/day) [10]Individuals who donated blood over 200mL in the past 1 month or over 400mL in the past 3 months [11]Individuals whose life style will change during the test period (ex. a night shift, travel for a long time, job transfer) [12]Individuals who participated in other clinical studies in the past three months [13]Individuals who are or are posslibly, or are lactating [14]Individuals judged inappropriate for the study by the principal

Design outcomes

Primary

MeasureTime frame
Oxidative stress test (Week 0, Week 4)

Secondary

MeasureTime frame
[1]Sleep-related hormone test (Week 0, Week 4) [2]Immunity test (Week 0, Week 4) [3]Inflammatory test (Week 0, Week 4) [4]Japanese version of the Pittsburgh Sleep Quality Index (Week 0, Week 4) [5]Anti-Aging QOL Common Questionnaire (Week 0, Week 4)

Countries

Japan

Contacts

Public ContactToshiyasu Tamura

TES Holdings Co., Ltd. Department of Clinical Trial

info@tes-h.co.jp03-6801-8480

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026